Wall Street analysts predict that Henry Schein, Inc. (NASDAQ:HSIC) will announce earnings per share of $0.86 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Henry Schein’s earnings. The highest EPS estimate is $0.88 and the lowest is $0.85. Henry Schein posted earnings per share of $1.03 in the same quarter last year, which indicates a negative year over year growth rate of 16.5%. The firm is expected to report its next earnings results on Tuesday, November 5th.

On average, analysts expect that Henry Schein will report full year earnings of $3.46 per share for the current financial year, with EPS estimates ranging from $3.44 to $3.48. For the next fiscal year, analysts expect that the firm will post earnings of $3.75 per share, with EPS estimates ranging from $3.66 to $3.80. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow Henry Schein.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.01. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.48 billion. Henry Schein had a return on equity of 16.67% and a net margin of 4.18%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 earnings per share.

A number of equities research analysts recently issued reports on the company. BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, July 24th. Barrington Research reaffirmed a “buy” rating and set a $75.00 price target on shares of Henry Schein in a research report on Wednesday, August 7th. Leerink Swann cut shares of Henry Schein from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $75.00 to $70.00 in a research note on Wednesday, May 15th. They noted that the move was a valuation call. Wolfe Research started coverage on shares of Henry Schein in a report on Thursday, May 30th. They issued an “underperform” rating on the stock. Finally, TheStreet downgraded shares of Henry Schein from a “b” rating to a “c+” rating in a report on Friday, August 30th. Seven analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the stock. Henry Schein currently has an average rating of “Hold” and an average target price of $73.64.

Shares of NASDAQ:HSIC traded up $1.94 during mid-day trading on Wednesday, reaching $65.84. 1,468,567 shares of the stock were exchanged, compared to its average volume of 1,671,180. The stock’s 50 day simple moving average is $63.08 and its 200-day simple moving average is $64.48. Henry Schein has a one year low of $56.58 and a one year high of $72.81. The company has a market cap of $9.28 billion, a P/E ratio of 15.94, a P/E/G ratio of 2.42 and a beta of 0.86. The company has a quick ratio of 0.95, a current ratio of 1.70 and a debt-to-equity ratio of 0.33.

In other Henry Schein news, Director E Dianne Rekow sold 3,500 shares of the business’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $71.18, for a total transaction of $249,130.00. Following the transaction, the director now owns 14,147 shares of the company’s stock, valued at approximately $1,006,983.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman James P. Breslawski sold 6,856 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $60.17, for a total value of $412,525.52. Following the sale, the insider now owns 249,046 shares in the company, valued at approximately $14,985,097.82. The disclosure for this sale can be found here. Insiders have sold 54,766 shares of company stock valued at $3,860,201 over the last three months. Insiders own 1.06% of the company’s stock.

Several large investors have recently added to or reduced their stakes in HSIC. Evergreen Capital Management LLC raised its holdings in shares of Henry Schein by 0.4% in the 1st quarter. Evergreen Capital Management LLC now owns 39,314 shares of the company’s stock valued at $2,363,000 after purchasing an additional 151 shares during the period. AGF Investments Inc. lifted its stake in Henry Schein by 6.3% in the 1st quarter. AGF Investments Inc. now owns 2,652 shares of the company’s stock valued at $159,000 after purchasing an additional 157 shares during the last quarter. Regentatlantic Capital LLC lifted its stake in Henry Schein by 1.4% in the 2nd quarter. Regentatlantic Capital LLC now owns 11,556 shares of the company’s stock valued at $808,000 after purchasing an additional 164 shares during the last quarter. Squar Milner Financial Services LLC grew its holdings in Henry Schein by 9.3% during the second quarter. Squar Milner Financial Services LLC now owns 2,037 shares of the company’s stock worth $142,000 after purchasing an additional 173 shares during the period. Finally, Rational Advisors LLC grew its holdings in Henry Schein by 24.9% during the second quarter. Rational Advisors LLC now owns 903 shares of the company’s stock worth $63,000 after purchasing an additional 180 shares during the period.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: Technical Analysis of Stocks, How Can It Help

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.